Related Experiment Videos
[The "e" antigen system in HBs antigen carriers (author's transl)]
La Nouvelle Presse Medicale
|October 14, 1978
Summary
Hepatitis B e antigen (HBeAg) was detected in carriers with acute and chronic active hepatitis, correlating with high HBs antigen titers. Its presence did not alter the disease course in chronic active hepatitis patients.
Area of Science:
- Hepatology and Virology
- Immunology
- Viral Hepatitis Research
Context:
- Hepatitis B virus (HBV) infection is a global health concern.
- Hepatitis B e antigen (HBeAg) is a key marker in HBV infection.
- Understanding HBeAg's role is crucial for managing chronic hepatitis B.
Purpose:
- To investigate the prevalence of Hepatitis B e antigen (HBeAg) and its antibody in HBs antigen carriers.
- To determine the association between HBeAg presence and HBs antigen titers.
- To assess the impact of HBeAg on the disease course in chronic active hepatitis.
Summary:
- Radial immunodiffusion was used to detect HBeAg in 86 HBs antigen carriers over one year.
- HBeAg was found in acute viral hepatitis, chronic active hepatitis, and some healthy carriers, but not in fulminant hepatitis.
- HBeAg presence significantly correlated with high circulating HBs antigen titers (p < 0.001).
Impact:
- Identifies HBeAg as a marker associated with higher HBs antigen levels.
- Suggests HBeAg detection can aid in characterizing HBV infection.
- Indicates HBeAg status does not influence disease progression in chronic active hepatitis patients with HBsAg.